SightLife is now the exclusive distributor for the KeraKlear artificial cornea in Japan....read more
KeraMed will have a booth at the 6th EUCORNEA Congress in Barcelona...read more
Come visit KeraMed at the XXXIII Congress of the ESCRS in Barcelona,...read more
Come visit KeraMed at AAO in Las Vegas, November 11-17, 2015. We...read more
Join the growing number of innovative surgeons around the globe that are treating cornea blindness with the KeraKlear...read more
Watch an interview of a Japanese cornea blind patient that achieved 20/20 vision with the KeraKlear artificial cornea. The...read more
Dr. Yichieh Shiuey won 3rd Place at the 2013 ESCRS Video Awards in the Innovative Category. Watch the...read more
Ziemer Ophthalmics AG is now the exclusive distributor for the KeraKlear artificial cornea in Germany, Austria and Switzerland....read more
The KeraKlear is indicated for patients that have non-inflammatory forms of corneal blindness (e.g. keratoconus, corneal dystrophies, corneal...Watch Video
The EndoInjector (Previously known as the Endoshield) is the latest generation device to enable delivery of a corneal...Watch Video
WAILEA, Hawaii – At Hawaiian Eye 2015, Monty Montoya, president and CEO of SightLife, discusses the organization’s achievements...Watch Video
John A. Kanellopoulos, MD, demonstrates the preparation of the KeraKlear II artificial cornea and shares the first clinical...Watch Video
KeraKlear Artificial Cornea
The KeraKlear is a revolutionary new type of foldable artificial cornea that is designed for synthetic lamellar keratoplasty through small incisions.
The KeraKlear is now available for treatment of all of the most common forms of cornea blindness including: keratoconus, corneal scars, corneal dystrophies, limbal stem cell deficiency, corneal edema and failed corneal transplants.
Can be implanted at depths from 300 microns to 700 microns to replace opacified or edematous corneal tissue.Learn more about the KeraKlear
KeraMed Inc. is an ISO 13485:2003 certified company which specializes in devices for minimally invasive corneal surgery. Each device has been designed to treat corneal conditions using smaller incisions than ever before possible. Smaller incisions can enable faster surgery, faster patient recovery, and maintain the structural strength of the cornea.
The EndoInjector and the KeraKlear Artificial Cornea have received European CE Mark approval.
CAUTION: The EndoInjector and the KeraKlear Artificial Cornea are investigational devices, limited by federal (U.S.) law to investigational use and are not available for sale in the United States.